Bruchim I - Search Results

1

Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group study.

Namazov A, Helpman L, Eitan R, Vaknin Z, Lavie O, Amit A, Levy T, Shachar IB, Atlas I, Bruchim I, Arie AB, Gemer O. Namazov A, et al. Among authors: bruchim i. Eur J Obstet Gynecol Reprod Biol. 2024 Feb;293:67-71. doi: 10.1016/j.ejogrb.2023.12.021. Epub 2023 Dec 17. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38118271

2

Sarcoma post-embolization for presumed uterine fibroids.

Buzaglo K, Bruchim I, Lau SK, Ferenczy A, Tulandi T, Gotlieb WH. Buzaglo K, et al. Among authors: bruchim i. Gynecol Oncol. 2008 Jan;108(1):244-7. doi: 10.1016/j.ygyno.2007.09.012. Epub 2007 Oct 22. Gynecol Oncol. 2008. PMID: 17950451

3

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.

Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Gotlieb WH, et al. Among authors: bruchim i. Gynecol Oncol. 2006 Feb;100(2):389-96. doi: 10.1016/j.ygyno.2005.09.048. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300820

4

Doxorubicin levels in the serum and ascites of patients with ovarian cancer.

Gotlieb WH, Bruchim I, Ben-Baruch G, Davidson B, Zeltser A, Andersen A, Olsen H. Gotlieb WH, et al. Among authors: bruchim i. Eur J Surg Oncol. 2007 Mar;33(2):213-5. doi: 10.1016/j.ejso.2006.11.006. Epub 2006 Dec 15. Eur J Surg Oncol. 2007. PMID: 17174514

5

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, Pollak MN, Bruchim I. Gotlieb WH, et al. Among authors: bruchim i. Gynecol Oncol. 2008 Aug;110(2):246-50. doi: 10.1016/j.ygyno.2008.04.008. Epub 2008 May 21. Gynecol Oncol. 2008. PMID: 18495226

6

Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta.

Petignat P, Laurini R, Goffin F, Bruchim I, Bischof P. Petignat P, et al. Among authors: bruchim i. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1679-84. doi: 10.1111/j.1525-1438.2006.00643.x. Int J Gynecol Cancer. 2006. PMID: 16884384 Free article.

7

Basic and clinical significance of IGF-I-induced signatures in cancer.

Werner H, Bruchim I. Werner H, et al. Among authors: bruchim i. BMC Med. 2010 Jan 5;8:2. doi: 10.1186/1741-7015-8-2. BMC Med. 2010. PMID: 20051101 Free PMC article.

8

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.

Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, Mirza MR, Brasiuniene B, Madry R, Brenton JD, Ausems MGEM, Büttner R, Lambrechts D; European experts’ consensus group. Vergote I, et al. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. Epub 2021 Dec 1. Ann Oncol. 2022. PMID: 34861371 Free article. Review.

9

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.

Bruchim I, Israeli O, Mahmud SM, Aviram-Goldring A, Rienstein S, Friedman E, Ben-Baruch G, Gotlieb WH. Bruchim I, et al. Cancer Genet Cytogenet. 2009 Apr 15;190(2):66-70. doi: 10.1016/j.cancergencyto.2008.11.013. Cancer Genet Cytogenet. 2009. PMID: 19380021

10

Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?

Petignat P, du Bois A, Bruchim I, Fink D, Provencher DM. Petignat P, et al. Among authors: bruchim i. Crit Rev Oncol Hematol. 2007 May;62(2):137-47. doi: 10.1016/j.critrevonc.2006.11.009. Epub 2006 Dec 26. Crit Rev Oncol Hematol. 2007. PMID: 17188887 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters